Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 460 News Items found In the Lab Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective Thursday, June 24, 2021 In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better. Feature 2013 Academic Convocation and Gerstner Sloan Kettering Graduate School Commencement Monday, July 8, 2013 Honors were conferred, PhD degrees were awarded, and a Pulitzer Prize-winning author addressed the graduates at the May 10 ceremony. Memorial Sloan Kettering, City College of New York Awarded $4M NIH Grant to Study the Use of Machine Learning in Early Breast Cancer Detection Monday, February 1, 2021 Memorial Sloan Kettering and the City College of New York (CCNY) were recently awarded a $4 million grant from the National Institutes of Health to study the use of machine learning for early breast cancer detection in high-risk women. Genetic Information Becomes a Vital Part of Clinical Practice Wednesday, October 1, 2008 At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients. Announcement MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status Thursday, September 18, 2014 The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute. Science Byte Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers Wednesday, November 1, 2017 A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA. Feature For People with a Rare Mouth Cancer, a Targeted Drug Can Be Lifesaving Thursday, January 23, 2020 The drug targets a protein called HER2 found on some salivary gland tumors. Event Olympic Gold Medalist and Cancer Survivor Shannon Miller Addresses Memorial Sloan Kettering Celebration Thursday, July 3, 2014 Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story. Announcement News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer Wednesday, April 20, 2016 At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach. Q&A Staying Heart-Healthy during and after Cancer Treatment Thursday, February 13, 2020 Learn how MSK works to keep people with cancer heart healthy. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer